Skip to main content
    E

    eXoZymes, Inc. (EXOZ)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $3.50
    -0.49 (-12.28%)

    Market Cap: $37.13M

    Last updated: Nov 17, 2026 at 4:10 PM ET

    eXoZymes, Inc. (EXOZ) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    eXoZymes (EXOZ) has a market cap of $37.13M and an enterprise value of $33.90M. Revenue fell 100.00% over the last 12 months from the 12 months before. Its share count is up 10.80% from a year earlier.

    Total Valuation

    Enterprise value is 8.70% below the market cap, as cash exceeds debt.

    Market Cap$37.13M
    Enterprise Value$33.90M
    Latest price (Nov 17, 2026)$3.50

    Key Dates

    The next earnings report is expected on Mar 29, 2027, covering the quarter ending Dec 31, 2026.

    Next Earnings DateMar 29, 2027 (expected)
    Last Earnings DateNov 13, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count rose 7.31% in the quarter ended Sep 30, 2026 and grew 21.91% a year over 2 years.

    Shares Outstanding9.29M
    Shares Change (YoY)+10.80%
    Shares Change (QoQ)+7.31%
    Share Count Growth (2Y CAGR)+21.91%

    Price Statistics

    The stock is down 77.06% over 52 weeks and trades 30.00% below its 50-day average.

    Beta (1Y)0.77
    52-Week Change-77.06%
    1-Month Change-12.50%
    3-Month Change-45.31%
    6-Month Change-63.16%
    Total Return (1Y)-77.06%
    Return vs SPY (1Y)-87.45%
    Max Drawdown (1Y)-78.36%
    Max Drawdown (3Y)-82.94%
    Sharpe Ratio (1Y)-1.84
    Correlation with SPY (1Y)0.14
    50-Day Average$5.00
    200-Day Average$7.36
    52-Week Range$3.24 to $16.90
    RSI (14 Days)33.9
    Average Volume (20 Days)13.68K

    Price chart

    Financial Position

    Current assets cover 2.30x current liabilities, and total debt is 0.01x shareholder equity.

    Current Ratio2.30x
    Quick Ratio2.30x
    Debt / Equity0.01x

    Returns and Efficiency

    Return on invested capital is -455.55% and return on equity is -462.82% over the last 12 months.

    Return on Equity (ROE)-462.82%
    Return on Assets (ROA)-173.00%
    Return on Invested Capital (ROIC)-455.55%
    Return on Capital Employed (ROCE)-245.31%
    ROA (5Y Average)-71.83%

    Scores

    EXOZ has a Piotroski F-Score of 1 of 9, in the weak band of 0 to 2.

    Piotroski F-Score1 of 9
    Piotroski StrengthWeak

    Income Statement

    Revenue was $0 over the last 12 months.

    Revenue$0
    Revenue Growth (YoY)-100.00%
    Gross Profit-$3.99M
    Operating Income-$11.08M
    Pretax Income-$10.25M
    Net Income-$10.14M
    EBITDA-$9.96M
    EBIT-$10.22M
    Reported EPS (TTM)-$1.17

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 37.37% of the $5.86M in total assets.

    Cash and Equivalents$3.26M
    Total Debt$28.98K
    Net Cash$3.23M
    Net Cash Per Share$0.35
    Working Capital$2.21M
    Shareholder Equity$2.19M
    Book Value Per Share$0.24
    Total Assets$5.86M
    Total Liabilities$3.67M

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    After $442.57K of capital spending, operating cash flow left -$7.80M of free cash flow.

    Operating Cash Flow-$7.36M
    Capital Expenditures$442.57K
    Free Cash Flow-$7.80M
    FCF Per Share-$0.84
    Depreciation and Amortization$361.80K

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Dividends and Yields

    EXOZ does not pay a dividend. Its free cash flow yield is -23.99%.

    FCF Yield-23.99%
    Buyback Yield0.00%
    Shareholder Yield0.00%

    Peer Position

    Against 3 similar companies, EXOZ has the lowest ROIC.

    ROIC-455.55% vs 22.19% median
    Revenue Growth (Trailing 4 Quarters, YoY)-100.00% vs -93.91% median

    Competitors compared

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Frequently Asked Questions About EXOZ

    What is EXOZ's market cap?

    eXoZymes has a market cap of $37.13M. Its enterprise value, which adds debt and subtracts cash, is $33.90M.

    How many shares of EXOZ are outstanding?

    eXoZymes has 9.29M shares outstanding. The count is up 10.80% from a year earlier.

    Does EXOZ pay a dividend?

    No. eXoZymes does not pay a dividend.

    How much debt does EXOZ have?

    eXoZymes has $28.98K of total debt and $3.26M of cash and equivalents, a net cash position of $3.23M.